A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19

Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Betacoronavirus
  • Biomarkers / blood
  • COVID-19
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / therapy*
  • Humans
  • Immunization, Passive
  • Pandemics / prevention & control
  • Plasma Exchange / methods*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / therapy*
  • Respiration, Artificial
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome

Substances

  • Biomarkers

Supplementary concepts

  • COVID-19 serotherapy